1.800.KIDS DOC | 1.800.543.7362

{{ item.title }}

Alexis A. Thompson, MD, MPH

Alexis A. Thompson, MD, MPH

Hematology Section Head; A. Watson and Sarah Armour Chair of Childhood Cancer and Blood Diseases

Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Clinical Interests: Hox A11 gene, plalelet disorders, bone marrow failure, thalassemia, hemophilia, sickle cell disease

Specialties, Programs & Conditions

Specialties:

Pediatric Hematology & Oncology >

Education & Training

Education: University of California (Health Services), LA, 1987 (MPH); Tulane University School of Medicine, 1983 (MD),

Postgraduate Training: Children's Hospital of Philadelphia, 1990; Children's Hospital of Los Angeles, 1986

Board Certifications: Pediatric Hematology-Oncology, General Pediatrics

Research

Research Interests: Sickle cell disease; thalassemia; blood transfusion; iron overload

Publications

Most recent publications

Gene Therapy in Patients with Transfusion-Dependent beta-Thalassemia N Engl J Med 378 (16): 1479-1493
Physician Decision Making in Selection of Second-Line Treatments in Immune Thrombocytopenia in Children Am J Hematol
Modifying factors of the health belief model associated with missed clinic appointments among individuals with sickle cell disease Hematology 1-9
The clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study Blood
Beliefs about hydroxyurea in youth with sickle cell disease Hematol Oncol Stem Cell Ther
Unrelated Donor Transplantation in Children with Thalassemia Using Reduced Intensity Conditioning - the URTH Trial Biol Blood Marrow Transplant
Medication Adherence and Technology-Based Interventions for Adolescents With Chronic Health Conditions: A Few Key Considerations JMIR Mhealth Uhealth 5 (12): e202
Enhancing clinical trial development for pediatric kidney diseases Pediatr Res 82 (5): 727-732
Impact of Enteroviral Polymerase Chain Reaction Testing on Length of Stay for Infants 60 Days Old or Younger J Pediatr 189 169-174 e2
Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults Health Qual Life Outcomes 15 (1): 136

Call 1.800.543.7362 for Insurance information. 1.800.543.7362

News

1 Results

Gene Therapy for Blood Disorder Ends Need for Transfusions

Gene Therapy for Blood Disorder Ends Need for Transfusions

See all News & Stories >